OPK

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

时间：2024-11-14 19:00:10 市场： 美股 综合

关联： NXPL 89988 09988 OPK BABA

NextPlat: Four-Year Extension of OPKO Healthcare E-Commerce Program in China

时间：2024-10-07 20:02:52 市场： 美股 综合

关联： 09988 NXPL OPK 89988 BABA

Modex Therapeutics Secures $35 Million Barda Supplement to Develop Covid Multispecific Antibodies and $16 Million to Initiate Influenza Program

时间：2024-10-07 20:02:36 市场： 美股 综合

关联： OPK

Entera Bio and OPKO Health Provide Update on Pk/Pd Results of Oral Oxyntomodulin (Glp-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders

时间：2024-09-25 20:30:01 市场： 美股 综合

关联： OPK

OPKO Health’s Modex Therapeutics Appoints DR. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances Into Clinical Development

时间：2024-09-23 20:00:02 市场： 综合 美股

关联： OPK

Labcorp Completes Acquisition of Select Assets of Bioreference Health's Diagnostics Business From OPKO Health

时间：2024-09-16 19:30:06 市场： 美股 综合

关联： OPK LH